A retrospective study of treatment persistence and adherence of tofacitinib and baricitinib in rheumatoid arthritis patients
Latest Information Update: 27 Jun 2022
At a glance
- Drugs Baricitinib (Primary) ; Tofacitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
Most Recent Events
- 27 Jun 2022 New trial record
- 04 Jun 2022 Results presented at the 23rd Annual Congress of the European League Against Rheumatism